China (Mainland)
Premiumsupplier
- Product Details
Keywords
- Lorlatinib (PF-06463922)
- 99% Lorlatinib
- Lorlatinib manufacturer
Quick Details
- ProName: Lorlatinib
- CasNo: 1454846-35-5
- Molecular Formula: C21H19FN6O2
- Appearance: white powder
- Application: Lorlatinib is a selective tyrosine kin...
- DeliveryTime: Within7-10 days after receipt of your ...
- PackAge: As customer request
- Port: Qingdao,China
- ProductionCapacity: 100 Kilogram/Week
- Purity: 99%
- Transportation: By Sea/Air/Courier
- LimitNum: 10 Gram
Superiority
Lorcaserin(856681-05-5)is an orally administered agent and a selective 5-HT2C receptor agonist for the treatment of obesity. It had been approved for marketing in US by FDA on 27 June in 2012. In clinical studies, lorcaserin has demonstrated efficacy in obese and overweight populations by promoting weight loss and improving metabolic parameters, and it is well tolerated.
Details
Lorlatinib (PF-06463922)
| CAS: | 1454846-35-5 |
| MF: | C21H19FN6O2 |
| MW:406.4129632 | 406.4129632 |
| Appearance: | White powder |
| Assay: | 99% |
| Boiling point: | 675.0±55.0 °C(Predicted) |
| desnity: | 1.42±0.1 g/cm3(Predicted) |
| Uses: | Lorlatinib is a selective tyrosine kinase receptor inhibitor used in the therapy of selected cases of advanced non-small cell lung cancer. |
